Enter multiple symbols separated by commas

Pros Say: Bypass Treasurys, Buy Corporate Bonds

Global stocks were lower Wednesday as investors were disappointed by the lack of clarity in new US Treasury Secretary Timothy Geithner's financial rescue plan. Experts tell CNBC that during the economic slowdown and market uncertainty, the bond market is the place to invest.

Buying Up Corporate Bonds

The current 10-year yields of Treasurys does not look attractive to Giles Keating, global head of research at Credit Suisse. He prefers corporate bonds with a tenure of about 3-4 years.

US Government Must Act Fast

The US risks wasting billions of taxpayers' money, if the government fails to act fast to resolve its banking problems, says Kenneth Rogoff, professor of public policy and economics at Harvard University. Partial nationalization of insolvent banks could be part of the solution, he suggests.

US Yet to Come to Terms with Scale of Bank Problems

Kenneth Rogoff, professor of public policy and economics at Harvard University, says many major US banks are insolvent and have to be put through receivership.

Investors Seek Clarity on US Bailout Plans

Investors needs more clarity on the valuations of the bailout package, says Rhonda Staskow, senior currency analyst at Action Economics.

Private Money Wants to Invest in Banks

Putting a floor on toxic assets will give clarity to the health of US banks and attract private capital to help them rebuild, says Peter Hoflich, associate editor with The Asian Banker.

Toxic Assets Still Looming

Trying to get a grasp on the banks' toxic assets is fundamental to a recovery in the sector, Mark Spelman from Growth and Strategy Accenture told CNBC Wednesday.

More on the US Bank Rescue Plan:

Contact Europe News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Europe Video

  • Should supermarkets warn on sugar content?

    Kawther Hashem, nutritionist and researcher for "Action on Sugar," explains why transparent labeling on sugary foods should be more widely used in U.K. supermarkets.

  • Teva to buy Allergan Generics for $40.5B

    Teva Pharmaceutical has announced plans to acquire Allergan's generic drug business for $40.5 billion. Ronny Gal, stock analyst at Sanford C. Bernstein, discusses.

  • China markets in frenzied fall

    On Monday, the Shanghai Composite had its biggest one-day drop since Feb 2007, yet Douglas Morton, head of Asia research at Aviate Global, explains why the moves aren't that extraordinary.